✦ LIBER ✦

Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders: A Prospective, Randomized Study

✍ Scribed by Thomas Cuisset; Corinne Frere; Jacques Quilici; Pierre-Emmanuel Morange; Jean-Philippe Mouret; Laurent Bali; Pierre-Julien Moro; Marc Lambert; Marie-Christine Alessi; Jean Louis Bonnet

Book ID: 108161402
Publisher: American College of Cardiology
Year: 2008
Tongue: English
Weight: 193 KB
Volume: 1
Category: Article
ISSN: 1936-8798
DOI: 10.1016/j.jcin.2008.08.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does platelet glycoprotein IIb/IIIa rece

Does platelet glycoprotein IIb/IIIa receptor antibody improve in-hospital outcome of coronary stenting in high-risk thrombus containing lesions?

✍ Chumpol Piamsomboon; Peter M.T. Wong; Atul Mathur; Davinderjit Singh; Ming W. Li 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Coronary stenting in acute coronary syndromes probably increases the risk of acute stent thrombosis. Recently, use of platelet glycoprotein IIb/IIIa receptor antibody has been shown to improve percutaneous transluminal coronary angioplasty (PTCA) outcomes in high risk lesions. The purpose of this an